Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 3 for Zhejiang Huahai Pharmaceutical Co., Ltd..
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Zhejiang Huahai Pharmaceutical Co., Ltd.: 0 warning letters, 0 recalls, 0 approval records, 3 Form 483s.
Side by side
Philips North America — Warning letters0
Zhejiang Huahai Pharmaceutical Co., Ltd. — Warning letters0
Philips North America — Recalls355
Zhejiang Huahai Pharmaceutical Co., Ltd. — Recalls0
Philips North America — Approval records0
Zhejiang Huahai Pharmaceutical Co., Ltd. — Approval records0
Philips North America — Form 483s0
Zhejiang Huahai Pharmaceutical Co., Ltd. — Form 483s3
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs Zhejiang Huahai Pharmaceutical Co., Ltd.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-zhejiang-huahai-pharmaceutical-co-ltd
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗